Cambridge Investment Research Advisors
PAHC icon

Cambridge Investment Research Advisors’s Phibro Animal Health PAHC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-17,345
Closed -$581K – 2212
2017
Q4 		$581K Buy
17,345
+2,321
+15% +$82.4K 0.01% 1237
2017
Q3 		$557K Buy
+15,024
New +$564K 0.01% 1198

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CRCP
Copper Rock Capital Partners Boston, Massachusetts $296M AUM 28.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DIA
Denver Investment Advisors Denver, Colorado $1.89B AUM 7.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cambridge Investment Research Advisors's PAHC Position: Q1 2018 in Review

Cambridge Investment Research Advisors sold out of Phibro Animal Health (PAHC) in Q1 2018, closing a stake of 17,345 shares — an estimated $581K sold.

Cambridge Investment Research Advisors first reported a position in PAHC in Q3 2017 and held it in 2 quarters. The position peaked at $581K in Q4 2017. 171 funds tracked by Wall St. Rank hold PAHC as of Q1 2018.

  • Cambridge Investment Research Advisors reported no remaining Phibro Animal Health position as of Q1 2018 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 17,345 Phibro Animal Health shares in Q1 2018, an estimated $581K.
  • Cambridge Investment Research Advisors first reported a position in Phibro Animal Health in Q3 2017 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's Phibro Animal Health position peaked at $581K in Q4 2017.
  • 171 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2018.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2018, filed 9 May 2018.